Deciphera Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Deciphera Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Deciphera Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $377M, a 15.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $377M +$49.8M +15.2% Dec 31, 2023 10-K 2024-02-07
Q4 2022 $327M +$44.8M +15.8% Dec 31, 2022 10-K 2024-02-07
Q4 2021 $283M +$79.4M +39.1% Dec 31, 2021 10-K 2024-02-07
Q4 2020 $203M +$83.5M +69.8% Dec 31, 2020 10-K 2023-02-07
Q4 2019 $120M +$71.5M +148% Dec 31, 2019 10-K 2022-02-08
Q4 2018 $48.2M +$37.4M +345% Dec 31, 2018 10-K 2021-02-09
Q1 2018 $10.8M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $10.8M Dec 31, 2017 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.